Division of Biological Sciences Faculty Selected for National Project on AI-Based Advanced Regenerative Medical Devices
- Views 926
- Writer 커뮤니케이션팀
- 보도일자 2026-05-12
(From left) Professors Kyunghyun Yoo, Jeongbok Lee and Byungchul Lee of the Division of Biological Sciences.
A research team led by Professors Kyunghyun Yoo, Jeongbok Lee and Byungchul Lee of the Division of Biological Sciences has been selected to participate as a collaborative research institution in a newly funded project under the Pan-governmental Advanced Medical Device Development Program. Through the initiative, the team will work to develop AI-based precision regenerative medical devices.
The program is a national research and development initiative jointly supported by four government ministries: the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, and the Ministry of Food and Drug Safety.
For the project, the university has formed an industry–academia–research–hospital consortium with regenerative medical device company PLCOskin, Kyung Hee University Dental Hospital, medical and 3D printing company BioFriends, and AI-powered medical imaging analysis company Xcube. The consortium will receive approximately KRW 5.6 billion in research funding over five years.
The research team will conduct studies that integrate patient-tailored regenerative medicine with translational applications by reflecting biological differences associated with age and sex. The project will focus on precisely analyzing variations in cellular and tissue-level responses and developing therapeutic strategies optimized for individual patient characteristics.
Through this initiative, the researchers aim to identify differences across key regenerative medicine processes—including bone regeneration, tissue healing, inflammatory responses, and vascularization—and translate these findings into practical therapeutic technologies.
“Our goal is to realize precision regenerative medicine tailored to individual patient characteristics,” the research team said. “By collaborating through global research networks, we aim to advance innovative technologies in regenerative medicine and expand their potential for clinical application.”